** Shares of medical device maker Inari Medical rise ~7% to $45.56 premarket
** Inari, late on Monday, raised the lower end of its full year 2024 revenue forecast to $601.5 million to $604.5 million, from its prior range of $594.5 million to $604.5 million
** Co's Q3 revenue of $153.39 mln beats analysts' average expectation of $150.67 mln - LSEG
** Co continues to expect to reach sustained operating profitability in first half of 2025
** At least two analysts have raised co's PT after results
** Up to last close, stock down 34.4% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Comments